日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Feasibility of Salvage Therapy With High-Dose Bendamustine and Rituximab Based on a Series of Two Cases From a Planned Phase II Trial for Relapsed/Refractory Diffuse Large B-cell Lymphoma

基于计划开展的II期临床试验中两例病例，评估高剂量苯达莫司汀联合利妥昔单抗挽救治疗复发/难治性弥漫性大B细胞淋巴瘤的可行性

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.102788
Murai, Kazunori; Hiramatsu, Yashushi; Kiguchi, Toru; Uoshima, Nobuhiko; Tamai, Yotaro; Fukushima, Koji; Furukawa, Takuma; Hoshiko, Toshimi; Takamori, Ayako; Mitsutake, Tubasa; Yoshida, Noriko; Kimura, Shinya; Terui, Yasuhito
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2026
文献求助 收藏

Long-term outcomes of venetoclax and ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

维奈托克和伊布替尼治疗日本复发/难治性套细胞淋巴瘤患者的长期疗效

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-025-02865-4
Goto, Hideki; Ito, Satoshi; Kizaki, Masahiro; Yamaguchi, Masaki; Fukuhara, Noriko; Kato, Koji; Saito, Toko; Terui, Yasuhito; Soshin, Tomomi; Satomi-Tsushita, Natsuko; Honda, Hideyuki; Qian, Chen; Izutsu, Koji
细胞生物学
淋巴瘤
发表日期：2025
文献求助 收藏

Plain language summary about tirabrutinib in relapsed/refractory primary central nervous system lymphoma

关于替拉布替尼治疗复发/难治性原发性中枢神经系统淋巴瘤的简明语言摘要

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2574838
Sugiyama, Kazuhiko; Narita, Yoshitaka; Nagane, Motoo; Mishima, Kazuhiko; Terui, Yasuhito; Arakawa, Yoshiki; Asai, Katsunori; Fukuhara, Noriko; Yonezawa, Hajime; Shinojima, Naoki; Aoi, Arata; Nishikawa, Ryo
淋巴瘤
神经科学
发表日期：2025
文献求助 收藏

Repeated Intravenous Methylprednisolone May Prevent Deterioration of Hypertrophic Pachymeningitis in Rosai-Dorfman Disease

反复静脉注射甲泼尼龙可能预防罗赛-多夫曼病肥厚性硬脑膜炎的恶化

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.3884-24
Tezuka, Toshiki; Nukariya, Tomonori; Takahashi, Nobuyuki; Kufukihara, Kenji; Tsuyama, Naoko; Terui, Yasuhito; Kameyama, Kaori; Nakahara, Jin; Takizawa, Tsubasa
神经科学
发表日期：2025
文献求助 收藏

IgG-Secreting Lymphoplasmacytic Lymphoma Presenting With Massive Kidney Infiltration

IgG分泌型淋巴浆细胞淋巴瘤伴大量肾脏浸润

期刊:Clinical Case Reports
影响因子:0.6
doi:10.1002/ccr3.71290
Nakamura, Yuichi; Itoh, Yoshihiro; Sakamoto, Tomoyuki; Kakegawa, Emi; Terui, Yasuhito; Tarusawa, Taichi; Inoue, Tsutomu; Okada, Hirokazu; Ishizawa, Keisuke; Yamada, Taketo
淋巴瘤
细胞生物学
IgG
发表日期：2025
文献求助 收藏

Three-year follow-up analysis of phase 1/2 study on tirabrutinib in patients with relapsed or refractory primary central nervous system lymphoma

一项针对复发或难治性原发性中枢神经系统淋巴瘤患者的tirabrutinib 1/2期研究的三年随访分析

期刊:NeuroOncology Advances
影响因子:4.1
doi:10.1093/noajnl/vdae037
Yonezawa, Hajime; Narita, Yoshitaka; Nagane, Motoo; Mishima, Kazuhiko; Terui, Yasuhito; Arakawa, Yoshiki; Asai, Katsunori; Fukuhara, Noriko; Sugiyama, Kazuhiko; Shinojima, Naoki; Aoi, Arata; Nishikawa, Ryo
淋巴瘤
神经科学
发表日期：2024
文献求助 收藏

Phase 2 study of ibrutinib plus venetoclax in Japanese patients with relapsed/refractory mantle cell lymphoma

一项针对复发/难治性套细胞淋巴瘤日本患者的伊布替尼联合维奈克拉的II期研究

期刊:International Journal of Clinical Oncology
影响因子:2.8
doi:10.1007/s10147-023-02443-6
Goto, Hideki; Ito, Satoshi; Kizaki, Masahiro; Yamaguchi, Masaki; Fukuhara, Noriko; Kato, Koji; Saito, Toko; Terui, Yasuhito; Okubo, Sumiko; Soshin, Tomomi; Zeng, Jiewei; Honda, Hideyuki; Badawi, Mohamed; Ross, Jeremy A; Izutsu, Koji
细胞生物学
淋巴瘤
发表日期：2024
文献求助 收藏

Successful Treatment of Diffuse Large B-cell Lymphoma Involving Multiple Renal and Bone Infiltrations Presenting with Giant Cell Arteritis-like Manifestations

成功治疗累及多发性肾脏和骨骼浸润并伴有巨细胞动脉炎样表现的弥漫性大B细胞淋巴瘤

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.2377-23
Yokota, Kazuhiro; Morimoto, Kota; Yazawa, Hiroaki; Tsuzuki Wada, Takuma; Sakamoto, Tomoyuki; Terui, Yasuhito; Kaneko, Satoru; Inoue, Tsutomu; Okada, Hirokazu; Akiyama, Yuji; Mimura, Toshihide
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2024
文献求助 收藏

Transformation into acute myeloid leukemia with t(8;21)(q22;q22.1); RUNX1::RUNX1T1 from JAK2-mutated essential thrombocythemia: a case report

由JAK2突变型原发性血小板增多症转化为伴有t(8;21)(q22;q22.1); RUNX1::RUNX1T1的急性髓系白血病：病例报告

期刊:Journal of Medical Case Reports
影响因子:0.8
doi:10.1186/s13256-024-04691-0
Asou, Chie; Sakamoto, Tomoyuki; Suzuki, Kodai; Okuda, Itoko; Osaki, Atsushi; Abe, Ryohei; Ito, Yoshihiro; Kakegawa, Emi; Miyakawa, Yoshitaka; Terui, Yasuhito; Nakamura, Yuichi
血小板
JAK/STAT
RUNX1
JAK2
白血病
发表日期：2024
文献求助 收藏

Polatuzumab vedotin in previously untreated DLBCL: an Asia subpopulation analysis from the phase 3 POLARIX trial

Polatuzumab vedotin 用于既往未接受治疗的弥漫性大B细胞淋巴瘤：来自 3 期 POLARIX 试验的亚洲亚组人群分析

期刊:Blood
影响因子:23.1
doi:10.1182/blood.2022017734
Song, Yuqin; Tilly, Hervé; Rai, Shinya; Zhang, Huilai; Jin, Jie; Goto, Hideki; Terui, Yasuhito; Shin, Ho-Jin; Kim, Won Seog; Cao, Junning; Feng, Jifeng; Eom, Hyeon Seok; Kim, Tae Min; Tsai, Xavier Cheng-Hong; Gau, Jyh-Pyng; Koh, Hideo; Zhang, Liling; Song, Yongping; Yang, Yu; Li, Wei; Huang, He; Ando, Kiyoshi; Sharman, Jeff P; Sehn, Laurie H; Bu, Lilian; Wang, Xin; Jiang, Yanwen; Hirata, Jamie; Lee, Calvin; Zhu, Jun; Izutsu, Koji
B细胞
细胞生物学
淋巴瘤
免疫/内分泌
发表日期：2023
文献求助 收藏